Enibarcimab 是一种人源化小鼠单克隆免疫球蛋白G1 (IgG1) 抗体，可用于急性心衰、COVID 2019 感染和感染性休克的研究。
| 生物活性 | Enibarcimab is a humanised murine monoclonalimmunoglobulin G1(IgG1) antibody, could be used for acute heart failure, COVID-19 infections and septic shock research[1]. |
| IC50& Target | Immunoglobulin G1; COVID-19[1] |
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com